supp.fit

Alpha-Lipoic Acid: study protocols

153 study groups say how much Alpha-Lipoic Acid participants took a day. These are the doses the studies gave. They are not a recommendation.

Alpha-Lipoic Acid: what the research found →

Dose per serving from products

3,150 products in our catalogue print how much Alpha-Lipoic Acid a serving holds.

Most common: 25 mg to 50 mg, 22% of 3,150 products.

Dose per servingProducts
2.5 mg or less
126
2.5 mg to 5 mg
66
5 mg to 10 mg
170
10 mg to 25 mg
405
25 mg to 50 mg
688
50 mg to 100 mg
490
100 mg to 250 mg
428
250 mg to 500 mg
333
500 mg to 1 g
369
over 1 g
75

Dose per serving from research

152 study groups in 114 studies say how much Alpha-Lipoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 60% of 152 study groups.

Daily doseStudy groups
100 mg or less
7
100 mg to 250 mg
5
250 mg to 500 mg
21
500 mg to 1 g
91
1 g to 2.5 g
28

Commonly used together

32 of 153 study groups took Alpha-Lipoic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin E
11
Vitamin C
6
Vitamin D
4
Vitamin B12
3
Vitamin B6
3
Zinc
3
superoxide dismutase (SOD)
3

153 study groups

Study
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation
2017 · ALA group · Adults aged 18–75 with symptomatic, drug-refractory paroxysmal atrial fibrillation who received catheter ablation
600 mg1 year49
Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor--a pilot study
2005 · alpha-lipoic acid group · Children with severe kwashiorkor
100 mg20 days—
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial
2011 · ALA · Adults aged 18–64 with type 1 or type 2 diabetes and mild-to-moderate diabetic distal symmetric sensorimotor polyneuropathy
600 mg4 years230
γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial
2020 · ALA and placebo · Adults aged 20–75 with type 2 diabetes and painful diabetic peripheral neuropathy
600 mg12 weeks50
The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines
2022 · ALA group · Women aged 20–50 with episodic migraine without aura and at least two attacks per month
300 mg90 days47
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial
2006 · ALA600 · Adults with diabetes and distal symmetric polyneuropathy; age and sex not specified
600 mg5 weeks45
The effect of alpha lipoic acid supplementation on sperm functions in idiopathic asthenozoospermic patients: a case-controlled study
2023 · treatment group A · primary infertile males with idiopathic asthenozoospermia
600 mg90 days40
Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients
2022 · ALA group · Adult women aged 18 to under 70 with stage II or III breast cancer receiving doxorubicin, cyclophosphamide, and paclitaxel chemotherapy
600 mg26 weeks32
Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study
2008 · group 2 (thioctic acid) · Adults aged 29–85 with acute backache and moderate sciatica associated with a herniated disc
600 mg60 days31
[Clinical effect of acupuncture combined with medication on diabetic peripheral neuropathy and its influence on serum lipid metabolism]
2024 · combined therapy group · Adults with diabetic peripheral neuropathy; age and sex not reported
600 mg4 weeks31
[Clinical effect of acupuncture combined with medication on diabetic peripheral neuropathy and its influence on serum lipid metabolism]
2024 · medication group · Adults with diabetic peripheral neuropathy; age and sex not reported
600 mg4 weeks29
Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes
2014 · T2DM patients receiving ALA · Adults with type 2 diabetes mellitus; mean age 59 ± 10 years
300 mg90 days28
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
1999 · TA 600 · Type 1 and Type 2 diabetic patients with symptomatic polyneuropathy
600 mg2 years27
Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial
2015 · group B (ALA) · Adults over 18 years with clinically diagnosed burning mouth syndrome and continuous oral burning pain for more than 4 months
600 mg60 days25
Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial
2011 · Group C · Patients with burning mouth syndrome
600 mg60 days20
Gastrointestinal Tolerability and Absorption of R- Versus R,S-Lipoic Acid in Progressive Multiple Sclerosis: A Randomized Crossover Trial
2020 · R-lipoic acid · Adults with progressive multiple sclerosis; mean age 59.6 years; 12 women overall
600 mg10 days20
The effects of alpha lipoic acid on muscle strength recovery after a single and a short-term chronic supplementation - a study in healthy well-trained individuals after intensive resistance and endurance training
2020 · ALA supplementation · Healthy, well-trained male sports students; mean age 23.5 years, with strength- and endurance-training experience
300 mg6 days17
Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading
2015 · ALA treatment · Adults with type 2 diabetes and symptomatic diabetic sensorimotor polyneuropathy who responded to initial treatment; age and sex not specified
600 mg16 weeks16
Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study
2005 · lipoic acid · People with metabolic syndrome; age and sex not specified
300 mg4 weeks15
Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study
2005 · irbesartan plus lipoic acid · People with metabolic syndrome; age and sex not specified
300 mg4 weeks15
Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes
2013 · Insulin plus alpha-lipoic acid · Children and adolescents aged 10–14 with asymptomatic type 1 diabetes; sex not specified
600 mg120 days15
Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes
2014 · Healthy controls receiving ALA · Healthy adults; mean age 33 ± 8 years
300 mg90 days14
Effect of Alpha-Lipoic Acid on Clinical and Neurophysiologic Recovery of Carpal Tunnel Syndrome: A Double-Blind, Randomized Clinical Trial
2018 · ALA treatment group · Adults with idiopathic carpal tunnel syndrome who underwent surgical decompression
600 mg90 days10
Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
2022 · Alpha lipoic acid group · Adults aged 18–65 of either sex with treatment-resistant schizophrenia
300 mg8 weeks10
Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes
2014 · T1DM patients receiving ALA · Adults with type 1 diabetes mellitus; mean age 43 ± 12 years
300 mg90 days5
Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study
2007 · LA · Adults with peripheral arterial disease; mean age 73.2 years; 15 men and 13 women across both study arms
600 mg90 days—
Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss
2015 · α-lipoic acid · Healthy overweight or obese women following an energy-restricted diet
300 mg10 weeks—
Alpha Lipoic Acid (ALA) effects on subchorionic hematoma: preliminary clinical results
2015 · case study: ALA and Progesterone group · Pregnant women in the first trimester with threatened miscarriage and ultrasound evidence of subchorionic hematoma
600 mg——
Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial
2016 · α-lipoic acid · Adults with diabetes and mild-to-moderate diabetic polyneuropathy
600 mg4 years—
Effects of probiotic and alpha-lipoic acid supplements, separately or in combination on the anthropometric indicators and maintenance of weight in overweight individuals
2021 · ALA group · Overweight individuals
600 mg24 weeks—
Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial
2021 · 400 mg/day ALA · Normoglycemic adults with idiopathic neuropathic pain, arthralgia, or myalgia; age and sex not specified
400 mg60 days—
Short-Term Dietary Caffeine Intake for Alleviating Symptoms of Burning Mouth Syndrome: A Randomised Controlled Comparison With Alpha-Lipoic Acid
2025 · ALA group · BMS patients; age and sex not specified
600 mg2 weeks—
Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
2020 · oral ALA · Patients with diabetic peripheral neuropathy; age range and sex not reported
1.2 g26 weeks100
α-Lipoic acid and superoxide dismutase in the management of chronic neck pain: a prospective randomized study
2014 · ALA/SOD plus physiotherapy · Adults over 18 with chronic neck pain lasting at least 3 months
600 mg60 days51
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial
2006 · ALA1200 · Adults with diabetes and distal symmetric polyneuropathy; age and sex not specified
1.2 g5 weeks47
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie
1997 · ALA · Patients with NIDDM and reduced heart rate variability, with cardiac autonomic neuropathy
800 mg122 days39
Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial
2015 · 10,000 ORAC antioxidant diet plus alpha-lipoic acid (group 1) · Adolescents aged 12–19 years with type 1 diabetes
800 mg26 weeks25
The synergic effects of alpha-lipoic acid supplementation and electrical isotonic contraction on anthropometric measurements and the serum levels of VEGF, NO, sirtuin-1, and PGC1-α in obese people undergoing a weight loss diet
2022 · α-LA · obese adults undergoing a weight-loss diet
1.2 g8 weeks25
The synergic effects of alpha-lipoic acid supplementation and electrical isotonic contraction on anthropometric measurements and the serum levels of VEGF, NO, sirtuin-1, and PGC1-α in obese people undergoing a weight loss diet
2022 · α-LA + Faradic · obese adults undergoing a weight-loss diet
1.2 g8 weeks25
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics
2024 · ALA group · Adults aged 18–60 with persistent post-COVID olfactory dysfunction, including smell loss and parosmia
800 mg180 days21
Gastrointestinal Tolerability and Absorption of R- Versus R,S-Lipoic Acid in Progressive Multiple Sclerosis: A Randomized Crossover Trial
2020 · R,S-lipoic acid mixture · Adults with progressive multiple sclerosis; mean age 59.6 years; 12 women overall
1.2 g10 days20
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
1999 · TA 1200 · Type 1 and Type 2 diabetic patients with symptomatic polyneuropathy
1.2 g2 years18
Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude
2001 · antioxidant group · Adults aged 35 ± 10 years ascending to high altitude; no diagnosed condition reported
600 mg31 days9
Effects of alpha-lipoic Acid on body weight in obese subjects
2011 · alpha-lipoic acid 1200 mg/d · Obese adults with BMI ≥30 kg/m², or BMI 27–30 kg/m² plus hypertension, diabetes mellitus, or hypercholesterolemia
1.2 g20 weeks—
Effects of lipoic acid on walking performance, gait, and balance in secondary progressive multiple sclerosis
2018 · lipoic acid (LA) · Adults aged 40–70 with secondary progressive multiple sclerosis (SPMS), able to walk at least 25 feet without an aid
1.2 g2 years—
Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial
2021 · 800 mg/day ALA · Normoglycemic adults with idiopathic neuropathic pain, arthralgia, or myalgia; age and sex not specified
800 mg60 days—
The role of oral alpha-lipoic acid as an adjuvant antioxidant therapy in diabetic nephropathy among children and adolescents with type 1 diabetes: a randomized controlled trial
2026 · interventional arm · children and adolescents with type 1 diabetes and diabetic nephropathy
300 mg90 days25
[Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy]
2010 · α-lipoic acid · People with diabetes and symptomatic polyneuropathy; age and sex not specified
1.8 g12 weeks117
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial
2006 · ALA1800 · Adults with diabetes and distal symmetric polyneuropathy; age and sex not specified
1.8 g5 weeks46
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy
1999 · TA group · Patients with type 2 diabetes mellitus and symptomatic polyneuropathy
1.8 g3 weeks12
Effects of alpha-lipoic Acid on body weight in obese subjects
2011 · alpha-lipoic acid 1800 mg/d · Obese adults with BMI ≥30 kg/m², or BMI 27–30 kg/m² plus hypertension, diabetes mellitus, or hypercholesterolemia
1.8 g20 weeks—
Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease
2010 · alpha-LA therapy · Patients with Parkinson's disease, low bone mineral density, and taking levodopa; age and sex not reported
1.2 g1 year—
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery
2025 · Group A: CBB + neurotrophic agents · Women aged over 18 with breast cancer undergoing breast-conserving surgery
400 mg30 days39
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy
1999 · A-A · Adults with type 2 diabetes and symptomatic polyneuropathy
600 mg29 weeks167
Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study)
2004 · Alpha-lipoic acid group · Adults with type 1 diabetes and autonomic neuropathy; mean age 38.1 years
600 mg60 days46
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics
2024 · Combined group · Adults aged 18–60 with persistent post-COVID olfactory dysfunction, including smell loss and parosmia
600 mg180 days28
Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus
2013 · alpha-lipoic acid · men with erectile dysfunction and type 2 diabetes mellitus
600 mg12 weeks—
Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss
2015 · EPA+α-lipoic acid · Healthy overweight or obese women following an energy-restricted diet
300 mg10 weeks—
Effects of probiotic and alpha-lipoic acid supplements, separately or in combination on the anthropometric indicators and maintenance of weight in overweight individuals
2021 · ALA and probiotic group · Overweight individuals
600 mg24 weeks—
The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals
2021 · dGTE+ · Adults over 18 who were recreationally active and overweight (BMI 25.0–29.9 kg/m² and/or body fat in the overweight category); healthy, without the listed cardio-metabolic or blood/liver disorders
150 mg8 weeks—
Effects of alpha lipoic acid on iron overload, lipid profile and oxidative stress indices in β-thalassemia major patients: A cross-over randomised controlled clinical trial
2021 · ALA · Patients with β-thalassemia major
600 mg8 weeks26
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers
2014 · Thioctacid HR (reference), part 2 · Healthy volunteers
600 mg1 day24
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers
2014 · PDT-2, part 2 · Healthy volunteers
600 mg1 day24
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers
2014 · Thioctacid HR (reference), part 1 · Healthy volunteers
600 mg1 day8
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers
2014 · PDT-1, part 1 · Healthy volunteers
600 mg1 day8
Pharmacokinetic evaluation of a newly developed piperazine dithioctate formulation in healthy volunteers
2014 · PDT-2, part 1 · Healthy volunteers
600 mg1 day8
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid
2002 · controlled-release LA (CRLA), pharmacokinetic study · 12 normal human subjects
600 mg1 day—
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid
2002 · quick-release LA (QRLA), pharmacokinetic study · 12 normal human subjects
600 mg1 day—
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers
1998 · oral 200 mg · 12 healthy volunteers; age and sex not stated
200 mg1 day—
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers
1998 · oral 600 mg · 12 healthy volunteers; age and sex not stated
600 mg1 day—
Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption
2012 · Antioxidant cocktail · Healthy young adults (mean age 25 ± 1 years) and older adults (mean age 71 ± 1 years), free of overt cardiovascular disease
600 mg1 day87
Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance
2014 · Antioxidant cocktail (AOC) · Adults: 30 patients with COPD and 30 age- and sex-matched controls
600 mg1 day60
Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial
2023 · Combo group (CG) · Adults aged 18–45 with acute sciatica due to lumbar disc herniation and low-back pain NRS 5–7
600 mg30 days44
Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy
2020 · Group A · Adults with type 2 diabetes, established peripheral and autonomic neuropathy, and at least four years of metformin treatment
570 mg1 year43
Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial
2023 · Supplement group (SG) · Adults aged 18–45 with acute sciatica due to lumbar disc herniation and low-back pain NRS 5–7
600 mg30 days41
Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years
600 mg26 weeks36
Effects of 12 Weeks of Essential Amino Acids (EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Mass, Muscle Strength, Muscle Power and Fatigue in Healthy Elderly Subjects: A Randomized Controlled Double-Blind Study
2019 · multi-ingredient nutritional supplement (SUPP) · Healthy men and women aged 65–80 years, not selected for a diagnosed disease; the group was described as non-sarcopenic and well-nourished
600 mg12 weeks19
Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up
2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years
140 mg26 weeks15
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study
2012 · QUI + ALA · Adults with diabetes and Stage I hypertension
600 mg8 weeks40
The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome
2013 · ALA · People with metabolic syndrome
600 mg1 year34
Effect of alpha lipoic acid on the blood cell count and iron kinetics in hypertensive patients
2014 · treatment group · Hypertensive adults, with or without anemia; age and sex not specified
600 mg12 weeks32
Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis
2012 · supplemented group · Adults aged 22–79 with end-stage renal disease undergoing maintenance hemodialysis
600 mg8 weeks31
Alpha lipoic acid supplementation improved antioxidant enzyme activities in hemodialysis patients
2019 · ALA group · Adults aged 22–79 with hemodialysis; 43 males and 20 females across the study
600 mg8 weeks31
Alpha-lipoic acid supplementation effects on serum values of some oxidative stress biomarkers in women with gestational diabetes
2021 · drug group · Women with gestational diabetes at 24–28 weeks of pregnancy
300 mg8 weeks30
Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: a multi-center prospective randomized controlled study
2022 · alpha-lipoic acid group · Adults with diabetes receiving hemodialysis
600 mg26 weeks30
Impact of Alpha Lipoic Acid as an Adjuvant Therapy on Inflammation and Fibrosis in Type 2 Diabetic Patients with Ischemic Cardiomyopathy: A Randomized Controlled Trial
2026 · ALA group · Adults aged 45–75 with type 2 diabetes and ischemic cardiomyopathy
600 mg90 days30
The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial
2015 · ALA group · Men with chronic spinal cord injury; age not reported
600 mg12 weeks28
The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
2011 · 600 mg LA · Patients with type 2 diabetes mellitus; age and sex not reported
600 mg120 days26
Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patients
2012 · ALA group · People with type 1 diabetes without evidence of cardiovascular disease; age and sex range not stated
600 mg5 weeks26
A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
2024 · ALA · Adults aged 30–65 of either sex with symptomatic diabetic peripheral neuropathy and type 2 diabetes, taking stable gabapentin or pregabalin
600 mg12 weeks26
Lack of interaction between thioctic acid, glibenclamide and acarbose
1999 · A (600 mg TA) · 24 healthy adult volunteers: 14 men and 10 women
600 mg1 day24
Lack of interaction between thioctic acid, glibenclamide and acarbose
1999 · C (600 mg TA + 3.5 mg glibenclamide) · 24 healthy adult volunteers: 14 men and 10 women
600 mg1 day24
Lack of interaction between thioctic acid, glibenclamide and acarbose
1999 · D (600 mg TA + 50 mg acarbose) · 24 healthy adult volunteers: 14 men and 10 women
600 mg1 day24
Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers
1998 · oral single-dose administration · Adults with insulin-dependent diabetes mellitus; gastric emptying was normal in 11 and delayed in 11
200 mg1 day22
[Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation]
1993 · alpha lipoic acid group · Patients with diabetes mellitus and long-term diabetic late syndrome; age and sex not reported
600 mg90 days20
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
1999 · 600 mg once daily · Patients with type-2 diabetes mellitus; age and sex not reported
600 mg4 weeks19
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women
2018 · α-LA group · Healthy sedentary overweight/obese women, mean age 37.3 years; following a hypocaloric diet
300 mg10 weeks16
Metabolic effects of α-lipoic acid supplementation in pre-diabetics: a randomized, placebo-controlled pilot study
2019 · α-lipoic acid treatment · Pre-diabetic, overweight/obese adults with dyslipidemia
600 mg30 days12
Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study
2007 · treatment group · Diabetic patients with end-stage renal disease undergoing hemodialysis
600 mg12 weeks—
The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males
2009 · Alpha-lipoic acid (ALA) · Healthy, physically active men
600 mg8 days—
Assessment of the antioxidant effectiveness of alpha-lipoic acid in healthy men exposed to muscle-damaging exercise
2009 · T(ALA) group · trained men; age and health condition not stated
600 mg8 days—
Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?
2009 · ALA group · Patients with controlled non-insulin dependent diabetes mellitus (NIDDM)
400 mg4 weeks—
Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients
2011 · ALA group · people with type 2 diabetes; age and sex not reported
300 mg8 weeks—
Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study
2012 · 300 mg/day ALA · Adults with type 2 diabetes mellitus
300 mg26 weeks—
Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study
2012 · 600 mg/day ALA · Adults with type 2 diabetes mellitus
600 mg26 weeks—
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy
2016 · α-lipoic acid (ALA) treatment · Patients with previous takotsubo cardiomyopathy
600 mg1 year—
Lack of a Clinically Significant Pharmacokinetic Interaction Between Pregabalin and Thioctic Acid in Healthy Volunteers
2018 · thioctic acid alone · healthy male volunteers; age not reported
600 mg——
Lack of a Clinically Significant Pharmacokinetic Interaction Between Pregabalin and Thioctic Acid in Healthy Volunteers
2018 · pregabalin and thioctic acid combination · healthy male volunteers; age not reported
600 mg——
Effect of lipoic acid supplementation on gene expression and activity of glutathione S-transferase enzyme in infertile men
2021 · lipoic acid group · Men with idiopathic asthenozoospermia
600 mg12 weeks—
A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations
2020 · (R)-α-lipoic acid (R-LA) · Overweight or obese adults aged 21–60 years with BMI ≥25 and elevated plasma triglycerides ≥100 mg/dL
600 mg24 weeks—
The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial
2021 · ALA group · Women with episodic migraine
600 mg90 days—
Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection
2008 · ALA · HIV-infected men and women aged 44–47 years with viral load >10,000 copies/cm(3) despite HAART
900 mg26 weeks—
The Beneficial Effects of α-Lipoic Acid in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
2018 · ALA group · Critically ill patients expected to stay at least seven days in the ICU and requiring enteral feeding
900 mg10 days40
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy
1997 · ALA · Adults with NIDDM and cardiac autonomic neuropathy diagnosed by reduced heart rate variability
800 mg120 days39
The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
2020 · intervention group (ALA group) · Adults aged 40–60 with type 2 diabetes for at least two years, HbA1c <7%, and BMI 18.5–29.9
1.2 g8 weeks35
Effect of Alpha-Lipoic Acid Supplementation on Endothelial Function and Cardiovascular Risk Factors in Overweight/Obese Youths: A Double-Blind, Placebo-Controlled Randomized Trial
2019 · ALA · Children and adolescents aged 8–16 years with overweight or obesity (BMI above the 85th percentile)
800 mg12 weeks34
Elevation of the adiponectin/leptin ratio in women with gestational diabetes mellitus after supplementation with alpha-lipoic acid
2019 · drug group · Pregnant women diagnosed with gestational diabetes mellitus at 24–28 weeks of pregnancy
100 mg8 weeks30
Reduction in maternal serum values of glucose and gamma-glutamyltransferase after supplementation with alpha-lipoic acid in women with gestational diabetes mellitus
2019 · drug group · Women aged 24–28 weeks of gestation with gestational diabetes mellitus
100 mg8 weeks30
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid
2002 · 900 mg CRLA daily, first treatment period · Patients with type 2 diabetes
900 mg6 weeks21
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid
2002 · 1,200 mg CRLA daily, second treatment period · Patients with type 2 diabetes
1.2 g6 weeks21
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
1999 · 1200 mg twice daily · Patients with type-2 diabetes mellitus; age and sex not reported
1.2 g4 weeks18
Effects of α-lipoic acid on mtDNA damage after isolated muscle contractions
2013 · α-lipoic acid supplement group · Apparently healthy men, mean age 28 years
1 g2 weeks6
Lipoic acid in multiple sclerosis: a pilot study
2005 · LA 600 mg twice a day · Patients with multiple sclerosis; age and sex not reported
1.2 g2 weeks—
Lipoic acid in multiple sclerosis: a pilot study
2005 · LA 1200 mg once a day · Patients with multiple sclerosis; age and sex not reported
1.2 g2 weeks—
Effect of cysteine derivatives administration in healthy men exposed to intense resistance exercise by evaluation of pro-antioxidant ratio
2007 · Alpha-lipoic acid (LIP) · Healthy men exposed to intense resistance exercise
1.2 g3 days—
Effects of sulphur-containing compounds on plasma redox status in muscle-damaging exercise
2009 · Alpha-lipoic acid (ALA) · Healthy, trained men
1.2 g3 days—
Oxidative stress in preretinopathic diabetes subjects and antioxidants
2012 · oral antioxidant treatment group · people with preretinopathic diabetes and good metabolic control
400 mg30 days—
Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study
2012 · 900 mg/day ALA · Adults with type 2 diabetes mellitus
900 mg26 weeks—
Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study
2012 · 1200 mg/day ALA · Adults with type 2 diabetes mellitus
1.2 g26 weeks—
Physical activity and alpha-lipoic acid modulate inflammatory response through changes in thiol redox status
2013 · αLA · Physically active males
1.2 g10 days—
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial
2014 · lipoic acid · Adults aged 18–50 years with relapsing-remitting multiple sclerosis and EDSS ≤5.5
1.2 g12 weeks—
Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial
2014 · LA consumption · Adults aged 18–50 with relapsing-remitting multiple sclerosis
1.2 g12 weeks—
α-Tocopherol supplementation reduces biomarkers of oxidative stress in children with Down syndrome: a randomized controlled trial
2014 · ALA · Children aged 7–15 years, both sexes, with Down syndrome
100 mg120 days—
Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features
2019 · α-LA group · Patients with non-alcoholic fatty liver disease; described as obese, ages and sex not reported
1.2 g12 weeks—
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALAPL group · Patients with diabetes; age and sex not reported
100 mg90 days20
The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
2019 · ALA · Obese patients with non-alcoholic fatty liver disease; age and sex not specified
1.2 g12 weeks23
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALA group · Patients with diabetes; age and sex not reported
100 mg90 days20
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
1999 · 1800 mg three times daily · Patients with type-2 diabetes mellitus; age and sex not reported
1.8 g4 weeks18
Lipoic acid in multiple sclerosis: a pilot study
2005 · LA 1200 mg twice a day · Patients with multiple sclerosis; age and sex not reported
2.4 g2 weeks—
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy
2013 · supplement group · Patients with diabetic nephropathy; age and sex not reported
800 mg12 weeks—
The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
2011 · 800 mg α-tocopherol + 600 mg LA · Patients with type 2 diabetes mellitus; age and sex not reported
600 mg120 days25
Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress
1999 · LA alone for 2 months, followed by LA and AT combination for 2 months · Healthy adults; age and sex not specified
600 mg120 days16
Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress
1999 · AT alone for 2 months, followed by LA and AT combination for 2 months · Healthy adults; age and sex not specified
600 mg120 days15
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women
2018 · EPA + α-LA · Healthy sedentary overweight/obese women, mean age 37.3 years; following a hypocaloric diet
300 mg10 weeks15
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease
2014 · ω-3 + LA · Adults aged 55 years or older with probable Alzheimer’s disease
600 mg1 year13
Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration
2003 · Creatine monohydrate + sucrose + alpha-lipoic acid · Male subjects aged 18–32 years
1 g5 days—
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
2012 · E/C/ALA · Adults aged 50–85 with probable Alzheimer disease and MMSE scores of 16 or more
900 mg16 weeks—
Effects of α-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study
2018 · supplement group · Obese adults with type 2 diabetes mellitus
7 mg/kg8 weeks—
A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients
2016 · food supplement containing α-lipoic acid · Caucasian adults aged 18–75 years, both sexes, with overweight and type 2 diabetes and HbA1c >7.0%
600 mg90 days54
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
2017 · Active nutraceutical · Adults with impaired fasting glucose, ages 54.6 ± 11.3 years on average; men and women
220 mg8 weeks20
Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation
2004 · antioxidant mixture · Healthy adult men and women who were active or passive smokers
95 mg60 days—
An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention
2016 · LAB4 ANTI · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon
400 mg90 days—
Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial
2011 · Group A · Patients with burning mouth syndrome
600 mg60 days20